Security key
19188J409
Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP)
CUSIP: 19188J409
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 13,831,528
- Total 13F shares
- 748,773
- Share change
- +37,384
- Total reported value
- $1,064,069
- Price per share
- $1.42
- Number of holders
- 23
- Value change
- +$47,078
- Number of buys
- 7
- Number of sells
- 7
Report period
Q1 2025
Institutions
23
Top holders
10
COCP full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Cocrystal Pharma, Inc. SEC filings
Cocrystal Pharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 19188J409
Recent filing periods:
Top shareholders of COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
2%
|
275,656
|
$556,825 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.91%
|
125,828
|
$254,173 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.53%
|
73,746
|
$148,967 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.5%
|
68,890
|
$139,188 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.47%
|
64,346
|
$129,980 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.15%
|
20,543
|
$41,497 | — | 31 Dec 2024 | |
| Parallel Advisors, LLC |
13F
|
Company |
0.11%
|
15,228
|
$30,761 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.11%
|
15,015
|
$30,330 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.09%
|
12,171
|
$24,585 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.09%
|
12,127
|
$24,497 | — | 31 Dec 2024 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.07%
|
10,000
|
$20,200 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
9,021
|
$18,222 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
6,130
|
$12,383 | — | 31 Dec 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
830
|
$1,677 | — | 31 Dec 2024 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.01%
|
817
|
$1,650 | — | 31 Dec 2024 | |
| Clean Yield Group |
13F
|
Company |
0%
|
418
|
$844 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
259
|
$523 | — | 31 Dec 2024 | |
| MAI Capital Management |
13F
|
Company |
0%
|
237
|
$479 | — | 31 Dec 2024 | |
| NVWM, LLC |
13F
|
Company |
0%
|
84
|
$170 | — | 31 Dec 2024 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
33
|
$67 | — | 31 Dec 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
6
|
$12 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
3
|
$6 | — | 31 Dec 2024 | |
| Activest Wealth Management |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Dec 2024 |
Institutional Holders of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) as of Q1 2025
As of 31 Mar 2025,
Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
748,773 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, NEUBERGER BERMAN GROUP LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, STATE STREET CORP, UBS Group AG, Parallel Advisors, LLC, and DIMENSIONAL FUND ADVISORS LP.
This page lists
23
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
23
Q1 2025 holders
23
Holder diff
0
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.